The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
Open accessAbstract
SUMMARY The histone lysine methyltransferase NSD2 (MMSET/WHSC1) is implicated in diverse diseases and commonly overexpressed in multiple myeloma due to a recurrent t(4;14) chromosomal translocation. However, the precise catalytic activity of NSD2 is obscure, preventing progress in understanding how this enzyme influences chromatin biology and myeloma pathogenesis. Here we show that dimethylation of histone H3 at lysine 36 (H3K36me2) is the principal chromatin-regulatory activity of NSD2. Catalysis of H3K36me2 by NSD2 is sufficient for gene activation. In t(4;14)-positive myeloma cells, the normal genome-wide and gene-specific distribution of H3K36me2 is obliterated, creating a chromatin landscape that selects for a transcription profile favorable for myelomagenesis. Catalytically active NSD2 confers xenograft tumor formation upon t(4;14)-negative cells, and promotes oncogenic transformation of primary cells in an H3K36me2-dependent manner. Together our findings establish H3K36me2 as the primary product generated by NSD2, and demonstrate that genomic disorganization of this canonical chromatin mark by NSD2 initiates oncogenic programming.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Palumbo, A., & Anderson, K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011442 · Cited by 2,326
Raje, N., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,163
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,418
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173 · cited 1×
“In contrast, SETD2, which synthesizes the bulk of H3K36me3 in diverse cells (Bell et al., 2007; Edmunds et al., 2008), acts like a tumor suppressor in clear cell renal cell carcinoma (Dalgliesh et al., 2010; Duns et al., 2010).”
BackgroundThe SET-domain protein superfamily: protein lysine methyltransferases.
Dillon, S. C., Zhang, X. Y., Trievel, R. C., & Cheng, X. (2005) · Genome biology · doi:10.1186/gb-2005-6-8-227 · Cited by 843
Krogan, N. J., Kim, M., Tong, A., Golshani, A., Cagney, G., Canadien, V., Richards, D. P., Beattie, B. K., Emili, A., Boone, C., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4207-4218.2003 · Cited by 686
Chesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation
Edmunds, J. W., Mahadevan, L. C., & Clayton, A. L. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601967 · Cited by 547
Kizer, K. O., Phatnani, H. P., Shibata, Y., Hall, H., Greenleaf, A. L., & Strahl, B. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3305-3316.2005 · Cited by 511
Statistical Issues in cDNA Microarray Data Analysis
Smyth, G. K., Yang, Y. H., & Speed, T. (2003) · Functional Genomics · doi:10.1385/1-59259-364-x:111 · Cited by 466
Spatial Distribution of Di- and Tri-methyl Lysine 36 of Histone H3 at Active Genes
Bannister, A. J., Schneider, R., Myers, F. A., Thorne, A. W., Crane-Robinson, C., & Kouzarides, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500796200 · Cited by 459
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites
Pei, H., Zhang, L., Luo, K., Qin, Y., Chesi, M., Fei, F., Bergsagel, P. L., Wang, L., You, Z., & Lou, Z. (2011) · Nature · doi:10.1038/nature09658 · Cited by 408
Keats, J. J., Reiman, T., Maxwell, C. A., Taylor, B. J., Larratt, L. M., Mant, M. J., Belch, A. R., & Pilarski, L. M. (2003) · Blood · doi:10.1182/blood-2002-06-1675 · Cited by 382
A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf–Hirschhorn syndrome
Nimura, K., Ura, K., Shiratori, H., Ikawa, M., Okabe, M., Schwartz, R. J., & Kaneda, Y. (2009) · Nature · doi:10.1038/nature08086 · Cited by 373
Martinez-Garcia, E., Popovic, R., Min, D.-J., Sweet, S. M. M., Thomas, P. M., Zamdborg, L., Heffner, A., Will, C., Lamy, L., Staudt, L. M., et al. (2011) · Blood · doi:10.1182/blood-2010-07-298349 · Cited by 360
Stec, I., Wright, T. J., van Ommen, G.-J. B., de Boer, P. A. J., van Haeringen, A., Moorman, A. F. M., Altherr, M. R., & den Dunnen, J. T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1071 · Cited by 308
Li, Y., Trojer, P., Xu, C.-F., Cheung, P., Kuo, A., Drury, W. J., Qiao, Q., Neubert, T. A., Xu, R.-M., Gozani, O., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034462 · Cited by 290
Self-citationAnderson, K. C., & Carrasco, R. D. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130249 · Cited by 258
Duns, G., van den Berg, E., van Duivenbode, I., Osinga, J., Hollema, H., Hofstra, R. M. W., & Kok, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0120 · Cited by 239
Marango, J., Shimoyama, M., Nishio, H., Meyer, J. A., Min, D.-J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P. L., Zhou, M.-M., et al. (2008) · Blood · doi:10.1182/blood-2007-06-092122 · Cited by 197
Genetic events in the pathogenesis of multiple myeloma
Chng, W. J., Glebov, O., Bergsagel, P. L., & Kuehl, W. M. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2007.08.004 · Cited by 188
Santra, M., Zhan, F., Tian, E., Barlogie, B., & Shaughnessy, J. (2003) · Blood · doi:10.1182/blood-2002-09-2801 · Cited by 184
Influence of Combinatorial Histone Modifications on Antibody and Effector Protein Recognition
Fuchs, S. M., Krajewski, K., Baker, R. W., Miller, V. L., & Strahl, B. D. (2011) · Current Biology · doi:10.1016/j.cub.2010.11.058 · Cited by 181
Bell, O., Wirbelauer, C., Hild, M., Scharf, A. N., Schwaiger, M., MacAlpine, D. M., Zilbermann, F., van Leeuwen, F., Bell, S. P., Imhof, A., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601926 · Cited by 171
Lauring, J. D., Abukhdeir, A. M., Konishi, H., Garay, J. P., Gustin, J. P., Wang, Q., Arceci, R. J., Matsui, W. H., & Park, B. H. (2007) · Blood · doi:10.1182/blood-2007-05-088674 · Cited by 162
Self-citationEpigenome Microarray Platform for Proteome-Wide Dissection of Chromatin-Signaling Networks
Bua, D. J., Kuo, A. J., Cheung, P., Liu, C. L., Migliori, V., Espejo, A. B., Casadio, F., Bassi, C., Amati, B. B., Bedford, M. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006789 · Cited by 99
Self-citationKim, J., Kee, H. J., Choe, N., Kim, S., Eom, G.-H., Baek, H. J., Kook, H. Y., Kook, H., & Seo, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02130-07 · Cited by 98
Creusot, R. J., Yaghoubi, S. S., Kodama, K., Dang, D., Dang, V. H., Breckpot, K., Thielemans, K., Gambhir, S. S., & Fathman, C. G. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.12.009 · Cited by 70
Cited by
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Writing, erasing and reading histone lysine methylations
Hyun, K., Jeon, J., Park, K., & Kim, J. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.11 · Cited by 1,250
Understanding the language of Lys36 methylation at histone H3
Wagner, E. J., & Carpenter, P. B. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3274 · Cited by 936
The genetic architecture of multiple myeloma
Morgan, G. J., Walker, B. A., & Davies, F. E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3257 · Cited by 913
Epigenetic reprogramming in cancer
Suvà, M. L., Riggi, N., & Bernstein, B. E. (2013) · Science · doi:10.1126/science.1230184 · Cited by 706
Metadata
- Authors
- Kuo, A. J., Cheung, P., Chen, K., Zee, B. M., Kioi, M., Lauring, J., Xi, Y., Park, B. H., Shi, X., Garcia, B. A., Li, W., & Gozani, O.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 44
- Issue
- 4
- Pages
- 609-620
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2058762628
- Cited by
- 443
- References
- 31
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.